Drug · DIN 02299216
RALIVIA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 25, 2021; first marketed October 25, 2007.
- Drug Identification Number (DIN)
- 02299216
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Narcotics (CDSA I)
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Tramadol N02AX02
- Class
- Human
- Record last updated
- May 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRAMADOL HYDROCHLORIDE | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 25, 2021: NOC 26146New Drug Submission (NDS)
- February 10, 2011: NOC 12056New Drug Submission (NDS) · Manufacturer name change
- August 31, 2007: NOC 9005New Drug Submission (NDS)
Other DINs named RALIVIA
- DIN 02299194 · Marketed
- DIN 02299208 · Marketed